Objective: To measure in vivo, using diffusion tensor magnetic resonance imaging (DT-MRI) the extent of pathological damage of normal appearing brain tissue (NABT) from patients with migraine. Methods: Dual echo and DT-MRI scans of the brain were acquired from 34 patients with migraine and 17 sex and age matched healthy volunteers. Mean diffusivity (MD) and fractional anisotropy (FA) histograms of the NABT were obtained from all subjects and the histograms' peak heights and average NABT MD and FA measured. When present, average MD and FA values of T2 visible lesions were also measured.
U sing T2 weighted magnetic resonance imaging (MRI), brain white matter abnormalities have been detected from patients with migraine with a frequency ranging from 12% to 46%. [1] [2] [3] [4] [5] Although the exact nature of these abnormalities is still unclear, they are likely to be the consequence of ischaemic damage secondary to the repeated regional blood flow reductions known to occur during headache episodes. 6 Recent in vivo studies of the human brain using diffusion tensor (DT) MRI has unambiguously shown that in longstanding vascular conditions, such as leukoaraiosis 7 and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), 8 there is a significant amount of tissue damage in the normal appearing brain tissue (NABT), which goes undetected when using conventional MRI.
To improve our understanding of white matter changes in patients with migraine and to investigate whether an association exists between the clinical phenomenology of the disease and an accurate estimate of the amount of brain damage, we measured, using DT-MRI and histogram analysis, 9 the extent of damage of NABT in migraine patients with different clinical and conventional MRI phenotypes. In those patients with T2 visible abnormalities, we also assessed the correlation between the extent of macroscopic and "occult" tissue damage.
PATIENTS AND METHODS
We studied 34 patients (31 women and three men; mean age 35.2 years, range 18-55 years; mean duration of the disease 13.6 years, range 1-40 years; mean number of episodes per year 44.6, range 12-70) with migraine. 10 All possible alternative diagnoses were carefully excluded. 10 There were 28 patients affected by "migraine without aura" and six patients affected by "migraine with aura". 10 Patients with hypertension, hypercholesteraemia, diabetes mellitus, vascular/ heart diseases, and other major systemic and neurological conditions were excluded. At the time of the MRI assessment, 11 patients were treated with prophylactic drugs. Seventeen sex and age matched healthy volunteers (15 women and two men; mean age 36.0 years, range 21-55 years) served as controls. These controls had a normal neurological examination, had not suffered from migraine, and did not have any medical conditions that have the potential to result in white matter abnormalities on MRI scans.
11
Local ethical committee approval and written informed consent from all the subjects were obtained before inclusion in the study.
Brain MRI scans were obtained using a 1.5 Tesla system. The following pulse sequences were acquired: (1) dual echo turbo spin echo (TSE) (TR/TE=3300/16-98, echo train length=5); and (2) pulsed gradient spin echo (PGSE) echo planar (interecho spacing=0.8 ms, TE=123 ms), with diffusion gradients applied in eight non-collinear directions, chosen in order to cover three dimensional space uniformly. 12 For the TSE scans, 24 contiguous axial slices were acquired with 5 mm slice thickness, 256×256 matrix and 250x250 mm field of view (FOV). The slices were positioned to run parallel to a line that joins the most inferoanterior and inferoposterior parts of the corpus callosum. 12 For the PGSE scans, 10 axial slices with 5 mm slice thickness, 128×128 matrix and 250x250 mm FOV were acquired, with the same orientation as the dual echo scans, with the second last caudal slice positioned to match exactly the central slices of the dual echo set.
Post-processing of MR data was performed by a single experienced observer, unaware to whom the scans belonged. Lesions were identified on the dual echo scans and lesion volumes were measured using a segmentation technique based on local thresholding. 12 PGSE images were first corrected for geometrical distortion induced by eddy currents. 12 Then, the diffusion tensor was calculated and mean diffusivity (MD) and fractional anisotropy (FA) derived for every pixel, as previously described. 12 The diffusion images were interpolated to the same image matrix size as the dual echo, and then the b=0 step of the PGSE scans (T2 weighted, but not diffusion weighted) was co-registered with the dual echo T2 weighted images. 12 Pixels containing extracerebral tissue (including the cerebrospinal fluid) were removed from the MD and FA maps, as previously described. 12 Whenever needed, the final step consisted of automatic transfer of lesion outlines onto the MD maps and calculation of average lesion MD and FA. To study the MD and FA of NABT, pixels lying inside lesion outlines were nulled out, and MD and FA histograms of the remaining NABT were produced, as previously described. 12 To correct for the between subject differences in brain volume, each histogram was normalised by dividing the height of each bin by the total number of pixels contributing to the histogram. For each histogram, the average MD and FA and the peak height were measured. Given the strong correlation existing between average histogram measures and the histogram peak location, 13 the second quantity was not considered for this study, to reduce the risk of type I errors.
Student's t test for unpaired data was used to compare MD and FA histogram derived metrics of the NABT between patients and controls and within patients with different clinical and MRI characteristics. Correlations were performed using the Spearman rank correlation coefficient.
RESULTS
White matter abnormalities were seen on the dual echo MRI scans from 14 patients with migraine (40%). No lesions were detected on the dual echo scans from controls. In patients with migraine, median dual echo lesion load was 2.5 ml (range 0.0-14. (fig 1) . No differences were found in FA histogram derived metrics between patients with migraine and controls. No difference in any MD and FA histogram derived metrics of the NABT was found between migraine patients with and without MRI lesions, and between migraine patients with and without aura (data not shown). In migraine patients with brain MRI abnormalities, average lesion MD was moderately correlated with MD histogram peak height of the NABT (r=−0.45; p=0.02).
DISCUSSION
Diffusion is the microscopic random translational motion of molecules, and water molecular diffusion can be measured in vivo using MR based technology. Because diffusion is affected by the properties of the medium where molecular motion occurs, measurements of diffusion inside biological tissues provide information about tissue structure at a microscopic level.
14 DT MRI has been applied for the measurement of tissue damage in several neurological conditions, and has proved to have the potential to provide a more accurate picture of the pathological changes associated with vascular 7-9 15 and demyelinating 12 13 16 17 conditions than conventional T2 weighted imaging, as white matter areas classified as normal at the visual inspection of dual echo scans were found to be sites of subtle abnormality, 7-9 12 13 16 17 which contributed to the clinical outcome. 7 8 16 17 We obtained conventional dual echo and DT MRI scans of the brain from patients with migraine to assess the extent and the severity of tissue damage within and outside macroscopic white matter lesions. In agreement with previous studies, [1] [2] [3] [4] [5] we found T2 visible lesions in 40% of the patients studied. We also measured MD of these lesions and found that, on average, MD was 3.4% higher than the MD of the NABT. In another study using the same DT-MRI sequence, 16 we found that, on average, the MD values of MS lesions visible on dual echo scans is about 19% higher than that measured in normal appearing white matter with a SD that was more than three times higher than that found for lesions of the present study. The average difference in MD values between T2 visible lesions and normal appearing white matter was reported to be about 20% in patients with CADASIL 8 and about 30% in patients with leukoaraiosis. 7 Similar considerations are also valid when comparing anisotropy of lesions with anisotropy of NABT in patients with migraine versus those with leukoaraiosis, 7 CADASIL, 8 and multiple sclerosis. 16 All of this suggests that the amount of tissue damage in T2 visible lesions of migraineurs is comparatively mild compared with that of other neurological conditions, and probably does not have a great deal of impact on the daily life management of these patients.
The most intriguing and novel part of this study is, however, the finding that brain abnormality in migraine extends beyond T2 visible lesions and also involves the NABT. We found a reduction of the peak height of the NABT MD histograms in patients with migraine compared with controls. The peak height of the MD histogram is considered a measure of the residual amount of "truly" normal tissue, 12 18-20 as mild but widespread NABT damage is expected to increase the number of pixels with high MD values, thus causing a reduction of the peak height. The discrepancy of this finding with that of a previous MTR study, 5 which was conducted on a different group of patients, is perhaps the result of a higher sensitivity of DT-MRI for the detection of ischaemic brain damage, 7 8 15 than MT MRI. Although this study cannot provide clear cut answers about the nature of NABT abmormality in patients with migraine (but definitive histopathological studies are unlikely to be ever performed), there are at least two possible explanations for the reduced peak height of the NABT MD histogram found in these patients. Firstly, DT-MRI changes in the NABT might be the result of mild ischaemic insults with the potential to cause a loss of structural barriers to water molecular motion that can be detected by DT-MRI, but not by conventional MRI. Secondly, NABT changes in migraine might reflect secondary Wallerian degeneration of fibres traversing the macroscopically damaged tissue. Clearly, this second mechanism cannot be operative in patients with no T2 visible lesions, whereas the two mechanisms are not mutually exclusive in the remaining patients.
